Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126680731 | 12668073 | 1 | I | 20101105 | 20160118 | 20160819 | 20160819 | EXP | JP-PRESTIUM-2016RN000360 | RENAISSANCE | NISHIOKA M, ET AL.. A CASE OF MULTIPLE DRUG ERUPTION DUE TO ZOVIRAX AND VITAMEDIN PROVED BY ORAL PROVOCATION TEST IN THE PATIENT WITH HERPES ZOSTER. JAPANESE JOURNAL OF CLINICAL DERMATOLOGY. 2016;70:21-26 | 0.00 | Y | 0.00000 | 20160819 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126680731 | 12668073 | 1 | PS | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 800 MG, TID | 16800 | MG | Y | Y | 20089 | 800 | MG | TABLET | TID | ||
| 126680731 | 12668073 | 2 | SS | VALACICLOVIR HYDROCHLORIDE | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | UNK | Y | U | 0 | ||||||||
| 126680731 | 12668073 | 3 | SS | VITAMEDIN /00274301/ | BENFOTIAMINECYANOCOBALAMINPYRIDOXINE HYDROCHLORIDE | 1 | Oral | UNK | Y | U | 0 | CAPSULE | |||||||
| 126680731 | 12668073 | 4 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | UNK | 0 | TABLET | ||||||||||
| 126680731 | 12668073 | 5 | C | COCARL | ACETAMINOPHEN | 1 | UNK | 0 | ORAL DRUG UNSPECIFIED FORM | ||||||||||
| 126680731 | 12668073 | 6 | C | ANAVAN | 2 | UNK | 0 | SUPPOSITORY |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126680731 | 12668073 | 1 | Herpes zoster |
| 126680731 | 12668073 | 2 | Product used for unknown indication |
| 126680731 | 12668073 | 3 | Herpes zoster |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126680731 | 12668073 | OT |
| 126680731 | 12668073 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126680731 | 12668073 | Alanine aminotransferase increased | |
| 126680731 | 12668073 | Drug eruption | |
| 126680731 | 12668073 | Drug-induced liver injury | |
| 126680731 | 12668073 | Erythema | |
| 126680731 | 12668073 | Face oedema | |
| 126680731 | 12668073 | Lymphadenopathy | |
| 126680731 | 12668073 | Papule | |
| 126680731 | 12668073 | Pyrexia | |
| 126680731 | 12668073 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126680731 | 12668073 | 1 | 20101030 | 20101107 | 0 | |
| 126680731 | 12668073 | 3 | 20101030 | 0 | ||
| 126680731 | 12668073 | 4 | 20101030 | 20101108 | 0 | |
| 126680731 | 12668073 | 6 | 20101030 | 0 |